James Samuel Shannon

Insider Reports History

Entity
Individual
Location
28903 North Avenue Paine, Valencia, CA
Signature
/s/ Julia Walcott, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Samuel Shannon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 50K Jun 13, 2024 Direct
MANNKIND CORP Director Restricted Stock Unit 35K May 15, 2024 Direct
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 Oct 6, 2023 By Trust
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co Director Restricted Stock Units 0 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co Director Stock Option (Right to Buy) 0 Oct 6, 2023 Direct

Insider Reports Filed by James Samuel Shannon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XLO Xilio Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
XLO Xilio Therapeutics, Inc. Jun 13, 2024 0 $0 3 Jun 17, 2024 Director
MNKD MANNKIND CORP May 15, 2024 1 $0 4 May 17, 2024 Director
HZNP Horizon Therapeutics Public Ltd Co Oct 6, 2023 5 -$6.62M 4 Oct 6, 2023 Director
HZNP Horizon Therapeutics Public Ltd Co Sep 29, 2023 2 $144K 4 Oct 2, 2023 Director
HZNP Horizon Therapeutics Public Ltd Co Jul 27, 2023 1 $0 4 Jul 28, 2023 Director
MNKD MANNKIND CORP May 25, 2023 1 $0 4 May 26, 2023 Director
HZNP Horizon Therapeutics Public Ltd Co Apr 28, 2023 3 -$209K 4 May 2, 2023 Director
MNKD MANNKIND CORP May 10, 2022 1 $0 4 May 12, 2022 Director
HZNP Horizon Therapeutics Public Ltd Co Apr 28, 2022 4 -$163K 4 May 2, 2022 Director
MNKD MANNKIND CORP May 20, 2021 2 $0 4 May 20, 2021 Director